Adding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.

by Thomas Celona

The Cancer Today editors share the most impactful reporting on cancer research from 2024.

by Cancer Today staff

Our favorite Cancer Today stories from 2024, as picked by the editors.

Chest radiation may not be necessary for people with intermediate-risk breast cancer.

by Thomas Celona

Active surveillance of DCIS patients may be an alternative to treatment, and guidelines add self-test for HPV.

by Kevin McLaughlin

Research finds certain people with low-risk DCIS may be able to forgo surgery or radiation.

by Thomas Celona

HPV vaccine credited for decrease in cervical cancer deaths among young women, and new technology extends survival in locally advanced pancreatic cancer.

by Thomas Celona

Most pancreatic ductal adenocarcinoma cases initially considered to be stage I are changed to a higher stage after surgery.

by Taneia Surles

Pancreatic cancer surge in younger people has not led to a rise in deaths, and researchers will study long-term survivors to better understand cancer responses.

by Eric Fitzsimmons

Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.

by Sandra Gordon